McKesson Corporation
NYSEShort interest in MCK surged 21% over the past week, reaching 2.5 million shares as of March 31. The healthcare distributor now has days to cover of 2.92. The one-week spike marks a sharp reversal. Over the past month, short interest climbed 35.5%. McKesson shares fell 2.4% over the past week and are down 4.9% over the month. Cost to borrow rose 33% week-over-week to 0.44%. Utilization sits at just 1.7%, down from a 52-week high of 4.62% in mid-March. Low utilization suggests ample shares remain available to short. Options sentiment turned slightly bullish. The put/call ratio dropped to 0.92, below the 20-day average of 0.99. That signals more call buying relative to puts. McKesson reports earnings May 6. The stock trades at $842.25. Short sellers appear to be positioning ahead of the event. This is not financial advice. ORTEX data may contain errors.
Short Sellers Pile Into McKesson
Short interest in MCK surged 21% over the past week, reaching 2.5 million shares as of March 31. The healthcare distributor now has days to cover of 2.92. The one-week spike marks a sharp reversal. Over the past month, short interest climbed 35.5%. McKesson shares fell 2.4% over the past week and are down 4.9% over the month. Cost to borrow rose 33% week-over-week to 0.44%. Utilization sits at just 1.7%, down from a 52-week high of 4.62% in mid-March. Low utilization suggests ample shares remain available to short. Options sentiment turned slightly bullish. The put/call ratio dropped to 0.92, below the 20-day average of 0.99. That signals more call buying relative to puts. McKesson reports earnings May 6. The stock trades at $842.25. Short sellers appear to be positioning ahead of the event. This is not financial advice. ORTEX data may contain errors.
Snapshot as of 7 May 2026
McKesson Corporation reports Q4 2026 results today having shed 16% of its value in the past month alone — the question heading into the print is whether the damage is idiosyncratic or the market is right to reprice the…
McKesson reports its fiscal fourth-quarter results on May 6 against a backdrop of falling targets, a stock down 6% over the past month, and an analyst consensus that still firmly says buy. The dominant signal heading…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MCK — free to start on ORTEX.
Sign up for free →Open MCK on ORTEX